MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
OPCH stock logo

OPCH

Option Care Health, Inc.

$27.47
0.98
 (3.7%)
[ms_data_label text=’Delayed data’]
Exchange:  NASDAQ
Market Cap:  4.36B
Shares Outstanding:  2.389M
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Care Facilities
   
CEO:  Luke Whitworth
Full Time Employees:  8000
Address: 
3000 Lakeside Drive
Bannockburn
IL
60015
US
Website:  https://www.optioncarehealth.com
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/04/30 — 1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue4,302,3244,998,2025,649,519
Gross Profit981,2231,012,9931,020,357
EBITDA472,190396,126408,596
Operating Income314,595321,833337,906
Net Income267,090211,823207,585

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets3,217,0353,421,7433,455,769
Total Liabilities1,795,3632,017,5052,129,376
Total Stockholders Equity1,421,6721,404,2381,326,393
Total Debt1,166,4121,217,9730
Cash and Cash Equivalents343,849412,565232,624

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow371,295323,392258,447
Capital Expenditure-41,86600
Free Cash Flow329,429323,392258,447
Net Income267,089.999211,823207,585
Net Change in Cash49,66368,716-179,941

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)8,228,358.744Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)8,432,432.639Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)8,330,629Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)705,581.706Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)723,081.041Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)714,351.380Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)448,254.847Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)462,761.291Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)455,524.052Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)1,126,421.108Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)1,154,357.802Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)1,140,421.394Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)2.850Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)2.900Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)2.800Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)2Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)1Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
4.998B  ?P/S
 (TTM)
: 
0.8
?Net Income
 (TTM)
: 
211.823M  ?P/E
 (TTM)
: 
21.95
?Enterprise Value
 (TTM)
: 
4.276B  ?EV/FCF
 (TTM)
: 
17.82
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
0.15  ?ROIC
 (TTM)
: 
0.09
?Net Debt
 (TTM)
: 
805.408M  ?Debt/Equity
 (TTM)
: 
?P/B
 (TTM)
: 
  ?Current Ratio
 (TTM)
: 

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MARKETSnap estimates OPCH intrinsic value between $27.53 – $31.45 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate OPCH Intrinsic Value

Common questions about OPCH valuation

Is OPCH (OPCH) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for OPCH (OPCH) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is OPCH a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether OPCH trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is OPCH’s P/E ratio?

You can see OPCH’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for OPCH?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is OPCH a good long-term investment?

Whether OPCH fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

OPCH

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

[ms_data_label text="Daily snapshot"]

3.7
MARKETSnap

Trading Metrics:

[ms_session_rows_unavailable]
Open: [ms_cell_or_dash table='trading_quote' column='open']   Previous Close: [ms_cell_or_dash table='trading_quote' column='previousClose']
Day Low: [ms_cell_or_dash table='trading_quote' column='dayLow']   Day High: [ms_cell_or_dash table='trading_quote' column='dayHigh']
Year Low:    Year High: 
Price Avg 50:    Price Avg 200: 
Volume:    Average Volume: 

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
See in Nexus

Relevant news

ATTENTION OPCH Investors: Securities Fraud Investigation Underway - Contact Levi & Korsinsky
Option Care Health, Inc. (OPCH) Q1 2026 Earnings Call Transcript
Option Care Health, Inc. Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation
Option Care (OPCH) Q1 Earnings Beat Estimates
Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of “Moderate Buy” by Analysts
Option Care (OPCH) Matches Q4 Earnings Estimates

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States
  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read